Research Article
Outcomes and Control Rates for I-125 Plaque Brachytherapy for Uveal Melanoma: A Community-Based Institutional Experience
Table 1
Patient and tumor characteristics.
| | | All treated patients | Patients with available F/U |
| | Number of Patients | 107 | 88 | | Age at diagnosis (yr) | | | | Median | 65 | 65 | | Range | 22–93 | 22–93 | | Sex | | | | Male | 60 (56%) | 48 (55%) | | Female | 47 (44%) | 40 (45%) | | Laterality | | | | Left | 56 (52%) | 47 (53%) | | Right | 51 (48%) | 41 (47%) | | Preexisting Conditions | | | | Hypertension | 50 (47%) | 40 (45%) | | CVS Disease | 16 (15%) | 12 (14%) | | Diabetes | 15 (14%) | 10 (11%) | | Smoking History | 17 (16%) | 18 (20%) | | COMS Classification | | | | Small | 13 (12%) | 12 (14%) | | Medium | 91 (85%) | 74 (84%) | | Large | 3 (3%) | 2 (2%) | | Stage | | | | T1a | 39 (36%) | 32 (36%) | | T1b | 1 (1%) | 1 (1%) | | T2a | 43 (40%) | 38 (43%) | | T2b | 5 (5%) | 5 (6%) | | T3a | 15 (14%) | 9 (10%) | | T3b | 3 (3%) | 3 (3%) | | T4a | 1 (1%) | 0 (0%) | | T4b | 0 (0%) | 0 (0%) | | Equatorial position | | | | Anterior | 8 (7%) | 7 (8%) | | Posterior | 70 (65%) | 58 (66%) | | Spanning | 25 (23%) | 20 (23%) | | Unknown | 4 (4%) | 3 (3%) |
|
|
F/U: follow-up; COMS: collaborative ocular melanoma study; CVS: cardiovascular.
|
